Ipamorelin does not suppress somatostatin release (unlike GHRH) and has minimal affinity for GHS-R1a splice variants associated with cortisol and prolactin release, explaining its superior endocrine selectivity profile
Any referenced fulfillment or delivery metrics reflect internal pharmacy processing data for approved prescriptions only and do not guarantee timelines, approval rates, medication access, or outcomes, as actual fulfillment may vary based on provider review, pharmacy operations, regulatory requirements, patient responsiveness, shipping conditions, inventory, and applicable state or federal requirements
Under the skin injections are less common and can occur in the belly area of the abdomen, fatty areas of the upper thigh or the back of the upper arm
any effects on GLP-1 pathways appear indirect and considerably less potent than prescription GLP-1 receptor agonists